Aiolos Bio

Aiolos is focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions.

Aiolos is a clinical-stage biopharmaceutical company focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions.

The company will advance its lead drug candidate, AIO-001, into a Phase 2 clinical trial in moderate-to-severe asthma patients and is actively evaluating additional development opportunities.